Mindfulness-based psychoeducation for people with major depression

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 18 to 65 treated as outpatients for depression for at least 6 months, living in Gaziantep city center.

Age

18 to 65 years

Sex

All sexes can join.

Disease stage

Depression diagnosed by DSM-V criteria, followed as an outpatient.

Earlier treatment

Must have been receiving treatment for depression for at least 6 months. Must not have taken part in a similar illness education program in the last 5 years.

Main reasons for not taking part

• Another mental illness alongside depression
• Intellectual disability or dementia that makes cooperation impossible
• Cannot read or write
• Receiving inpatient (hospital) treatment
• Does not agree to the interview

The registry criteria, word for word

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

• Are you between 18 and 65 years old?YesNo

What the trial wants to find out

Major depression is a mental illness that seriously threatens public health, leading to disability, reduced quality of life, economic burden, and premature death. It is estimated that 18.4% of the world's population lived with depression between 2005 and 2015, and it is projected to be a leading cause of global disease burden by 2030. Major depressive disorder manifests with symptoms such as decreased interest and desire, a depressed mood, increased or decreased sleep and appetite, feelings of worthlessness and guilt, decreased energy, suicidal thoughts and attempts, leading to significant impairment in functioning. Choosing the appropriate treatment for depression and taking measures to improve the individual's functionality quickly, shorten hospital stays, and reduce the number of hospitalizations are crucial. In addition to pharmacological treatment, clinical guidelines recommend the combined use of pharmacological and psychosocial interventions in the treatment of depression. The mindfulness-based cognitive therapy, which forms the basis of the psychoeducation planned for this study, was developed as an 8-week group approach. Theoretical studies examining emotion regulation mechanisms have indicated that mindful awareness is a fundamental mechanism for emotion regulation. The literature suggests a negative correlation between mindful awareness and the severity of depressive symptoms and difficulty in emotion regulation. Furthermore, despite numerous descriptive, correlational, and experimental studies on major depression, no studies have been found demonstrating the effect of mindful awareness-based psychoeducation on emotion regulation difficulties, distress tolerance, and symptom severity in patients diagnosed with major depression. This study, therefore, differs from existing research and will make a significant contribution to the literature.

The 2 groups in the trial

• control groupNo study treatment, for comparison

  The control group will be administered the pre-test scales. Participants will not receive any intervention. Then, the same scales will be administered as a post-test, and a follow-up test using the same scales will be conducted two months later.

• experimental groupExisting treatment, for comparison

  Pre-test scales will be administered to participants in the experimental group. Participants will receive mindfulness-based psychoeducation. Then, post-test scales consisting of the same scales will be administered, and a follow-up test consisting of the same scales will be conducted 2 months later.

  Treatment: Mindfulness-based psychoeducation